Investing.com -- CVS Health (NYSE: CVS) will not include Gilead Sciences (NASDAQ: GILD )’ new HIV prevention drug Yeztugo in its commercial plans for the time being, despite the medication’s proven ...

The analysis reveals a clear hierarchy among the four largest U.S. banks, with value-oriented opportunities leading the pack ...

HOUSTON - National Energy Services Reunited Corp. (NASDAQ:NESR) reported second-quarter adjusted earnings that exceeded analyst expectations, driven by sequential revenue growth and improved ...

At the conclusion of its July meeting, the Federal Open Market Committee, or FOMC, voted to keep its benchmark rate to a ...

The judge emphasized that the government already possesses a substantial trove of records about the case that it has chosen not to make public, which far exceeds the limited grand jury materials in ...

Perhaps surprisingly, the pound dropped after the release and was –0.3% versus the euro at 0.866. Usually, currencies rally ...

Nasdaq 100, S&P 500, Microsoft Corporation, Goldman Sachs Group Inc. Read 's Market Analysis on Investing.com UK.

The most obvious beneficiaries are small-cap companies, which have been disproportionately hit by elevated borrowing costs. Small businesses are still paying very high rates even on short-term loans, ...

It’s been a rough year for the residential property market, but the tide is turning favorable again, or so the recent rally in homebuilder shares suggest. A closer look, however, reminds that ...

Our EUR/USD view is quite US-centric, and the major risks to our baseline scenario also stem from US macro. The biggest is that US inflation proves too high and/or too persistent to hinder the Fed’s ...

Two FOMC members dissented at the last meeting, favoring a rate cut while the majority opted to keep rates unchanged. Markets are currently indicating an 84% chance for a quarter-point rate cut at the ...

Investing.com -- Daiwa Capital Markets downgraded Applied Materials (NASDAQ: AMAT) to Neutral from Outperform and lowered its ...